Endocyte Inc
(ECYT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,533 | 48,572 | 31,569 | 32,855 | 52,847 |
| Marketable Securities | 79,536 | 79,997 | 89,534 | 91,319 | 70,434 |
| Receivables | 706 | 3,946 | 5,279 | 5,354 | 6,353 |
| Other current assets | 653 | 680 | 811 | 954 | 496 |
| TOTAL | $127,038 | $134,327 | $128,675 | $135,034 | $133,332 |
| Non-Current Assets | |||||
| PPE Net | 3,971 | 4,145 | 4,163 | 3,856 | 3,839 |
| Investments And Advances | 81,761 | 82,535 | 98,098 | 7,370 | 25,572 |
| Other Non-Current Assets | 31 | 31 | 11 | 220 | 115 |
| TOTAL | $85,763 | $86,712 | $102,271 | $11,446 | $29,526 |
| Total Assets | $212,801 | $221,039 | $230,946 | $146,480 | $162,858 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,235 | 1,107 | 3,491 | 3,665 | 5,436 |
| Accrued Expenses | 5,650 | 8,170 | 11,724 | 8,306 | 8,463 |
| Other current liabilities | N/A | 13 | 16 | 18 | 18 |
| TOTAL | $6,885 | $9,340 | $15,280 | $57,723 | $73,664 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 50 | 50 | 45,734 | 59,747 |
| Other Non-Current Liabilities | 30 | 25 | 28 | 30 | 34 |
| TOTAL | $912 | $920 | $935 | $949 | $965 |
| Total Liabilities | $7,797 | $10,260 | $16,215 | $58,672 | $74,629 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,887 | 41,710 | 41,551 | 41,505 | 36,181 |
| Common Shares | 42 | 42 | 42 | 36 | 36 |
| Retained earnings | -168,465 | -160,385 | -154,710 | -177,066 | -173,925 |
| Other shareholders' equity | -144 | -75 | -38 | 48 | 57 |
| TOTAL | $205,004 | $210,779 | $214,731 | $87,808 | $88,229 |
| Total Liabilities And Equity | $212,801 | $221,039 | $230,946 | $146,480 | $162,858 |